Skip to main content
Top
Published in: Pediatric Rheumatology 1/2018

Open Access 01-12-2018 | Research article

Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study

Authors: Jacqueline K. K. Sit, Winnie K. Y. Chan

Published in: Pediatric Rheumatology | Issue 1/2018

Login to get access

Abstract

Background

Accumulated damage is an important prognostic factor in systemic lupus erythematous. However, the pattern of disease damage and its risk factors have not been well studied in childhood-onset systemic lupus erythematosus (cSLE) in Asia. The objectives are to evaluate the pattern of damage and to identify the risk factors for accumulated damage in an Asian group of cSLE.

Methods

A retrospective chart review was conducted on a group of 59 patients with cSLE. Patient demographics and clinical variables were first collected at diagnosis. Over the course of their disease, clinical variables considered as risk factors for damage were also collected. Damage was measured using the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology Damage Index (SDI) for each patient at their last encounter. Based on their SDI scores, patients were then dichotomized to two groups: a group with presence of disease damage (SDI ≥1) and a group with absence of disease damage (SDI score = 0). Clinical variables including age at diagnosis, gender, ethnicity, disease duration, disease manifestations, laboratory values at diagnosis, disease activity at diagnosis and last encounter, major organ involvement, number of lupus flares, major infection, and intensity of immunosuppressive medications were compared between the two groups. Growth failure and estimated glomerular filtration rate (eGFR) were also analysed as secondary outcomes.

Results

After a median disease duration and follow up of 7.8 years, 39 patients (66.1%) had no disease damage while 20 patients (33.9%) had acquired disease damage. Disease damage most frequently occurred in the ocular (15.3%), neuropsychiatric (11.9%) and musculoskeletal (11.9%) domains. The most frequent forms of damage were cataracts (11.9%), and avascular necrosis (unilateral and bilateral combined 10.2%). After controlling for other variables, presence of neuropsychiatric manifestations remained the only statistically significant risk factor for damage. The rate of growth failure in our group of patients was 16%. Patients who experienced growth failure were significantly younger at disease diagnosis. The median age of diagnosis was 10 for those who experienced growth failure, whereas the median age of diagnosis was 13 for those who did not experience growth failure. Despite a high rate of renal involvement in the group (79.7%), renal damage was only seen in 3.2% of the patients. 91.5% of the studied group had normal eGFR of ≥90 ml/min/1.73m2 at their last follow up.

Conclusion

This group of patients had a low rate of damage accrual, with one of the lowest rates in renal damage when compared to other cohorts reported. The presence of neuropsychiatric manifestations was identified as the most significant risk factor for disease damage, while the most frequent forms of damage were cataracts and avascular necrosis, which were both related to prolonged steroid use. Despite the limitations of this study, it highlights the need for larger prospective studies to understand the relationship between childhood-onset SLE and its resulting damage.
Literature
1.
go back to reference Mina R, Brunner HI. Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin N Am. 2010;36(1):53–80. vii-viiiCrossRef Mina R, Brunner HI. Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin N Am. 2010;36(1):53–80. vii-viiiCrossRef
2.
go back to reference Gonzalez B, et al. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile. Lupus. 2005;14(11):918–23.CrossRefPubMed Gonzalez B, et al. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile. Lupus. 2005;14(11):918–23.CrossRefPubMed
4.
go back to reference Miettunen PM, et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol. 2004;31(8):1650–4.PubMed Miettunen PM, et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol. 2004;31(8):1650–4.PubMed
5.
go back to reference Brunner HI, Huggins J, Klein-Gitelman MS. Pediatric SLE--towards a comprehensive management plan. Nat Rev Rheumatol. 2011;7(4):225–33.CrossRefPubMed Brunner HI, Huggins J, Klein-Gitelman MS. Pediatric SLE--towards a comprehensive management plan. Nat Rev Rheumatol. 2011;7(4):225–33.CrossRefPubMed
6.
go back to reference Bandeira M, et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus. 2006;15(8):515–20.CrossRefPubMed Bandeira M, et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus. 2006;15(8):515–20.CrossRefPubMed
7.
go back to reference Brunner HI, et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum. 2002;46(2):436–44.CrossRefPubMed Brunner HI, et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum. 2002;46(2):436–44.CrossRefPubMed
8.
go back to reference Lee PP, et al. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage. Rheumatology (Oxford). 2007;46(8):1290–6.CrossRef Lee PP, et al. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage. Rheumatology (Oxford). 2007;46(8):1290–6.CrossRef
9.
go back to reference Lilleby V, Flato B, Forre O. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol. 2005;23(2):261–9.PubMed Lilleby V, Flato B, Forre O. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol. 2005;23(2):261–9.PubMed
10.
go back to reference Ravelli A, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum. 2003;49(4):501–7.CrossRefPubMed Ravelli A, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum. 2003;49(4):501–7.CrossRefPubMed
12.
go back to reference Tucker LB, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008;17(4):314–22.CrossRefPubMedPubMedCentral Tucker LB, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008;17(4):314–22.CrossRefPubMedPubMedCentral
13.
go back to reference Gladman D, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363–9.CrossRefPubMed Gladman D, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363–9.CrossRefPubMed
14.
go back to reference Brunner HI, et al. Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus. J Rheumatol. 2009;36(7):1536–45.CrossRefPubMed Brunner HI, et al. Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus. J Rheumatol. 2009;36(7):1536–45.CrossRefPubMed
15.
go back to reference Hoi A. Asian lupus in a multi-ethnic society: what can be learnt? Int J Rheum Dis. 2015;18(2):113–6.CrossRefPubMed Hoi A. Asian lupus in a multi-ethnic society: what can be learnt? Int J Rheum Dis. 2015;18(2):113–6.CrossRefPubMed
16.
go back to reference Shaharir SS, et al. Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) cohort: comparison with other cohorts worldwide. PLoS One. 2016;11(11):e0166270.CrossRefPubMedPubMedCentral Shaharir SS, et al. Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) cohort: comparison with other cohorts worldwide. PLoS One. 2016;11(11):e0166270.CrossRefPubMedPubMedCentral
17.
go back to reference Tan EM, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.CrossRefPubMed Tan EM, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.CrossRefPubMed
18.
go back to reference Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRefPubMed Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRefPubMed
19.
go back to reference Petri M, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.CrossRefPubMedPubMedCentral Petri M, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.CrossRefPubMedPubMedCentral
20.
go back to reference Bombardier C, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35(6):630–40.CrossRefPubMed Bombardier C, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35(6):630–40.CrossRefPubMed
21.
go back to reference Lattanzi B, et al. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician’s Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI). Arthritis Care Res. 2011;63(Suppl 11):S112–7.CrossRef Lattanzi B, et al. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician’s Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI). Arthritis Care Res. 2011;63(Suppl 11):S112–7.CrossRef
22.
go back to reference Liang, M. H., et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599-608. Liang, M. H., et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599-608.
23.
go back to reference Ruperto N, et al. International consensus for a definition of disease flare in lupus. Lupus. 2011;20(5):453–62.CrossRefPubMed Ruperto N, et al. International consensus for a definition of disease flare in lupus. Lupus. 2011;20(5):453–62.CrossRefPubMed
24.
go back to reference Gutierrez-Suarez R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2006;54(9):2989–96.CrossRefPubMed Gutierrez-Suarez R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2006;54(9):2989–96.CrossRefPubMed
25.
go back to reference Leung SSF, et al. Standards for the anthropometric assessment of nutritional status of Hong Kong children. Hong Kong J Paediatr. 1995;12(1):5–15. Leung SSF, et al. Standards for the anthropometric assessment of nutritional status of Hong Kong children. Hong Kong J Paediatr. 1995;12(1):5–15.
26.
go back to reference Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832–43.CrossRefPubMed Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832–43.CrossRefPubMed
28.
go back to reference Nived O, et al. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol. 2002;29(7):1398–400.PubMed Nived O, et al. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol. 2002;29(7):1398–400.PubMed
29.
go back to reference Ravelli A, Ruperto N, Martini A. Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol. 2005;17(5):568–73.CrossRefPubMed Ravelli A, Ruperto N, Martini A. Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol. 2005;17(5):568–73.CrossRefPubMed
30.
go back to reference Johnson SR, et al. Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J Rheumatol. 2006;33(10):1990–5.PubMed Johnson SR, et al. Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J Rheumatol. 2006;33(10):1990–5.PubMed
31.
go back to reference Mok CC, et al. Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2003;30(7):1513–9.PubMed Mok CC, et al. Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2003;30(7):1513–9.PubMed
32.
go back to reference Watson L, et al. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum. 2012;64(7):2356–65.CrossRefPubMed Watson L, et al. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum. 2012;64(7):2356–65.CrossRefPubMed
33.
go back to reference Peschken CA, et al. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. J Rheumatol. 2009;36(6):1200–8.CrossRefPubMed Peschken CA, et al. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. J Rheumatol. 2009;36(6):1200–8.CrossRefPubMed
34.
go back to reference Yap DY, Chan TM. Treatment of lupus nephritis: practical issues in Asian countries. Int J Rheum Dis. 2015;18(2):138–45.CrossRefPubMed Yap DY, Chan TM. Treatment of lupus nephritis: practical issues in Asian countries. Int J Rheum Dis. 2015;18(2):138–45.CrossRefPubMed
35.
go back to reference Yu HH, et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus. 2006;15(10):651–7.CrossRefPubMed Yu HH, et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus. 2006;15(10):651–7.CrossRefPubMed
36.
go back to reference Sibbitt WL Jr, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29(7):1536–42.PubMed Sibbitt WL Jr, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29(7):1536–42.PubMed
37.
go back to reference Olfat MO, Al-Mayouf SM, Muzaffer MA. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol. 2004;23(5):395–9.CrossRefPubMed Olfat MO, Al-Mayouf SM, Muzaffer MA. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol. 2004;23(5):395–9.CrossRefPubMed
38.
go back to reference Rygg M, et al. A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus. Ann Rheum Dis. 2012;71(4):511–7.CrossRefPubMed Rygg M, et al. A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus. Ann Rheum Dis. 2012;71(4):511–7.CrossRefPubMed
Metadata
Title
Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study
Authors
Jacqueline K. K. Sit
Winnie K. Y. Chan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2018
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-018-0271-8

Other articles of this Issue 1/2018

Pediatric Rheumatology 1/2018 Go to the issue